

3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| RMP Thread | October 2025 | $6M | $3.4M | 11 |
| RMP RepScrubs | December 2024 | $4.7M | $4.7M | 22 |
| Rockmont GrowthTech Fund I QP | March 2024 | $50M | $41M | 103 |
| Rockmont GrowthTech Fund I | March 2024 | $5M | $4.1M | 22 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
3 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Curt Futch | Selective | None listed | 5 | 3 |
| Samuel Bartholomew, III | Slowing | None listed | 10 | 1 |
| Charles Fox | Quiet | Manufacturing & industrials | 8 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Too few companies classified yet to infer a focus. 1 of 13 portfolio companies are classified.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Rockmont Partners’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Tectonic Ventures | 1 | Healthcare Value Analytics |
A shared board seat: a company where filings name a Rockmont Partners partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.